HIF1A and hepatocellular carcinoma: As shown in Supplementary Fig. 2A and 2B, Exo-SR showed no promotion on the viability of endothelial cells (HUVEC) in response to sorafenib stress and did not influence the expression of VEGF and HIF-1α in HCC cells.